Access to the most advanced scientific research and a long period of clinical trials on the real different biochemical responses of tissues to treatments have allowed the development of the most advanced and effective line.
The sequential technology developed to produce hyaluronic acid with a wide range of molecular weights has allowed the development of different modulations of hyaluronic acid. Each of the different configurations is thus able to ensure the best functional integration in the tissues under all clinical conditions.
Cross-linked high molecular weight hyaluronic acid of very high purity, in combination with a specific number of selected fragments of hyaluronic acid, to create a new, unique, and effective formulation. The hyaluronic acid fragments, in chains of 20-38 monomers, interact with CD44 receptors on fibroblasts, activating biochemical processes to produce interfibrillar reticular collagen.
A modulated cross-linking technique capable of achieving excellent volumetric yield and perfect tissue integration.
DIFFERENTIAL CROSS-LINKING
The different configurations thus allow for optimal functionality for each specific clinical application.
BEYOND THE STATE OF THE ART
-MW Sequence
-Fragments of Hyaluronic Acid
-Fundamental Amino Acids
-Differential Cross-Linking
Application Intent:
Luxfill SUB-Q
LuxFill Plus is CE approved hyaluronic acid filler that provides natural facial volume. LuxFill has high viscoelasticity and long duration compared to existing other fillers. It is completely degraded within
July 11, 2024
